Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning

Abstract

Background: Patients prescribed with medication that treats mental health conditions benefit the most compared to those prescribed with other types of medication. However, they are also the most difficult to adhere. The development of mobile health (mHealth) applications (“apps”) to help patients monitor their adherence is fast growing but with limited evidence on their efficacy. There is no evidence on the content of these apps for patients taking psychotropic medication. The aim of this study is to identify and evaluate the aims and functioning of available apps that are aiming to help and educate patients to adhere to medication that treats mental health conditions.Method: Three platform descriptions (Apple, Google, and Microsoft) were searched between October 2015 and February 2016. Included apps need to focus on adherence to medication that treats mental health conditions and use at least a reinforcement strategy. Descriptive information was extracted and apps evaluated on a number of assessment criteria using content analysis.Results: Sixteen apps were identified. All apps included self-monitoring properties like reminders and psycho-educational properties like mood logs. It was unclear how the latter were used or how adherence was measured. Major barriers to medication adherence like patients' illness and medication beliefs and attitudes were not considered nor where information to patients about mediation side effects. Very few apps were tailored and none was developed based on established theories explaining the processes for successful medication adherence like cognitions and beliefs. Reported information on app development and validation was poor.Discussion: A variety of apps with different properties that tackle both intentional and unintentional non-adherence from a different perspective are identified. An evidence-based approach and co-creation with patients is needed. This will ensure that the apps increase the possibility to impact on non-adherence. Theories like social cognition models can be useful in ensuring that patients' education, motivation, skills, beliefs, and type of adherence are taken into consideration when developing the apps. Findings from this study can help clinicians and patients make informed choices and pursue policy-makers to integrate evidence when developing future apps. Quality-assurance tools are needed to ensure the apps are systematically evaluated.

The use of smartphone apps in clinical practice: A survey of South African physiotherapists

“…The most commonly reported purpose for using apps was to retrieve information, followed by the use of reminders and communication apps that were used to interact with colleagues and/or patients. These findings are similar to what has been reported in the literature, where apps for reminders and communication have been used to improve patient compliance and appointment attendance (Kassianos et al 2017;Schwebel & Larimer 2018). There is evidence that the use of appointment reminders can reduce patients' nonattendance, which has led to improved outcomes (Moran, O'Loughlin & Kelly 2018).…”

Suicidal Behavior and Medication Adherence in Schizophrenic Patients

“…The physician should also help in simplifying the medication regimen if it is too difficult for the patient to understand. A psychosocial intervention like CBT is a recommended treatment modality nowadays besides medication for Schizophrenia [ 39 , 40 ]. It helps to evaluate the distressing and problematic behavior of the patients thinking, their self internalized stigma regarding diagnosis, anxiety, and fear of dependency on the medication.…”

Mobile Mental Health Apps in China: Systematic App Store Search (Preprint)

“…This may partly be motivated by market considerations (ie, smaller target user population), but could also reflect the current lack of consensus about evidence-based guidelines for mHealth therapy for mental health patients. There is a large body of international literature about the use of mHealth interventions for people with mental health disorders [11,[48][49][50] and similar work has been carried out in China [51]; however, the development of smartphone-based therapy is still in quite an early phase, and it may indeed be too early to offer it outside an experimental or academic mental health care setting. At this point, there is still a long way to go, both in terms of app development and efficacy evaluation, before evidence-based mHealth therapy can be routinely offered to patients in China.…”